|
|
||||||||
Radiology, Vol 196, 471-478, Copyright © 1995 by Radiological Society of North America
ARTICLES |
KD Hagspiel, KF Neidl, AC Eichenberger, W Weder and B Marincek
Department of Medical Radiology, University Hospital Zurich, Switzerland.
PURPOSE: To compare the sensitivities of superparamagnetic iron oxide- enhanced and unenhanced magnetic resonance (MR) imaging at 1.5 T with those of percutaneous ultrasound (US), intraoperative US (IOUS), and dynamic computed tomography (CT) in the preoperative assessment of metastatic liver disease. MATERIALS AND METHODS: Eighteen patients with liver metastases who were candidates for curative surgery underwent presurgical imaging. Thirteen patients underwent surgery and IOUS after undergoing preoperative US, CT, and MR imaging. RESULTS: In the preoperative imaging group, the standard of reference was the total number of lesions detected with any of the modalities. Superparamagnetic iron oxide-enhanced MR imaging was the most sensitive modality (99%). In the surgical group, the standard of reference was the total number of metastases identified at IOUS and pathologic examination. IOUS had the highest sensitivity (80%), followed by superparamagnetic iron oxide-enhanced MR imaging (56%). CONCLUSION: Superparamagnetic iron oxide-enhanced high-field-strength MR imaging facilitates the preoperative evaluation of potentially curable metastatic liver disease; however, it is inferior to IOUS.
This article has been cited by other articles:
![]() |
J. Ward, J. A. Guthrie, M. B. Sheridan, S. Boyes, J. T. Smith, D. Wilson, J. I. Wyatt, D. Treanor, and P. J. Robinson Sinusoidal Obstructive Syndrome Diagnosed With Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging in Patients With Chemotherapy-Treated Colorectal Liver Metastases J. Clin. Oncol., September 10, 2008; 26(26): 4304 - 4310. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gultekin, C. Yucel, H. Ozdemir, H. Celik, S. O. Oktar, and M. Arac The role of late-phase pulse inversion harmonic imaging in the detection of occult hepatic metastases. J. Ultrasound Med., September 1, 2006; 25(9): 1139 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Kim, K. W. Kim, J. H. Byun, H. J. Won, Y. M. Shin, P. N. Kim, M.-S. Lee, and M.-G. Lee Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. Am. J. Roentgenol., April 1, 2006; 186(4): 1059 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Onishi, T. Murakami, T. Kim, M. Hori, R. Iannaccone, M. Kuwabara, H. Abe, S. Nakata, K. Osuga, K. Tomoda, et al. Hepatic Metastases: Detection with Multi-Detector Row CT, SPIO-enhanced MR Imaging, and Both Techniques Combined Radiology, April 1, 2006; 239(1): 131 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ward, P. J. Robinson, J. A. Guthrie, S. Downing, D. Wilson, J. P. A. Lodge, K. R. Prasad, G. J. Toogood, and J. I. Wyatt Liver Metastases in Candidates for Hepatic Resection: Comparison of Helical CT and Gadolinium- and SPIO-enhanced MR Imaging Radiology, October 1, 2005; 237(1): 170 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bipat, M. S. van Leeuwen, E. F. I. Comans, M. E. J. Pijl, P. M. M. Bossuyt, A. H. Zwinderman, and J. Stoker Colorectal Liver Metastases: CT, MR Imaging, and PET for Diagnosis--Meta-analysis Radiology, October 1, 2005; 237(1): 123 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Sahani, S. P. Kalva, A. J. Fischman, R. Kadavigere, M. Blake, P. F. Hahn, and S. Saini Detection of Liver Metastases from Adenocarcinoma of the Colon and Pancreas: Comparison of Mangafodipir Trisodium-Enhanced Liver MRI and Whole-Body FDG PET Am. J. Roentgenol., July 1, 2005; 185(1): 239 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Kim, A. Y. Kim, T. K. Kim, S. H. Park, H. J. Kim, Y. K. Lee, M.-S. Park, H. K. Ha, P. N. Kim, J. C. Kim, et al. Small (l.e. 2cm) Hepatic Lesions in Colorectal Cancer Patients: Detection and Characterization on Mangafodipir Trisodium-Enhanced MRI Am. J. Roentgenol., May 1, 2004; 182(5): 1233 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsuo, M. Kanematsu, K. Itoh, T. Murakami, Y. Maetani, H. Kondo, S. Goshima, N. Kako, H. Hoshi, J. Konishi, et al. Detection of Malignant Hepatic Tumors with Ferumoxides-Enhanced MRI: Comparison of Five Gradient-Recalled Echo Sequences with Different TEs Am. J. Roentgenol., January 1, 2004; 182(1): 235 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Huppertz, T. Balzer, A. Blakeborough, J. Breuer, A. Giovagnoni, G. Heinz-Peer, M. Laniado, R. M. Manfredi, D. G. Mathieu, D. Mueller, et al. Improved Detection of Focal Liver Lesions at MR Imaging: Multicenter Comparison of Gadoxetic Acid-enhanced MR Images with Intraoperative Findings Radiology, January 1, 2004; 230(1): 266 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumano, T. Murakami, T. Kim, M. Hori, A. Okada, T. Sugiura, Y. Noguchi, S. Kawata, K. Tomoda, and H. Nakamura Using Superparamagnetic Iron Oxide-Enhanced MRI to Differentiate Metastatic Hepatic Tumors and Nonsolid Benign Lesions Am. J. Roentgenol., November 1, 2003; 181(5): 1335 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ward, J. A. Guthrie, D. Wilson, P. Arnold, J. P. Lodge, G. J. Toogood, J. I. Wyatt, and P. J. Robinson Colorectal Hepatic Metastases: Detection with SPIO-enhanced Breath-hold MR Imaging—Comparison of Optimized Sequences Radiology, September 1, 2003; 228(3): 709 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Bluemke, T. M. Weber, D. Rubin, E. E. de Lange, R. Semelka, R. D. Redvanly, J. Chezmar, E. Outwater, R. Carlos, S. Saini, et al. Hepatic MR Imaging with Ferumoxides: Multicenter Study of Safety and Effectiveness of Direct Injection Protocol Radiology, August 1, 2003; 228(2): 457 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Frate, C. Zuiani, V. Londero, G. Como, M. Bazzocchi, K. Mortele, and P. R. Ros Comparing Levovist-Enhanced Pulse Inversion Harmonic Imaging and Ferumoxides-Enhanced MR Imaging of Hepatic Metastases Am. J. Roentgenol., May 1, 2003; 180(5): 1339 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Kang, J. H. Lim, S. H. Kim, D. Choi, H. K. Lim, W. J. Lee, and S. J. Lee Preoperative Depiction of Hepatocellular Carcinoma: Ferumoxides-enhanced MR Imaging versus Triple-Phase Helical CT Radiology, January 1, 2003; 226(1): 79 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
T H Saunders, H K Mendes Ribeiro, and F V Gleeson New techniques for imaging colorectal cancer: the use of MRI, PET and radioimmunoscintigraphy for primary staging and follow-up Br. Med. Bull., December 1, 2002; 64(1): 81 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Del Frate, M. Bazzocchi, K. J. Mortele, C. Zuiani, V. Londero, G. Como, R. Zanardi, and P. R. Ros Detection of Liver Metastases: Comparison of Gadobenate Dimeglumine-enhanced and Ferumoxides-enhanced MR Imaging Examinations Radiology, December 1, 2002; 225(3): 766 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. van Erkel, M. E. J. Pijl, A. A. van den Berg-Huysmans, M. N. J. M. Wasser, C. J. H. van de Velde, and J. L. Bloem Hepatic Metastases in Patients with Colorectal Cancer: Relationship between Size of Metastases, Standard of Reference, and Detection Rates Radiology, August 1, 2002; 224(2): 404 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
W H Allum, S M Griffin, A Watson, and D Colin-Jones Guidelines for the management of oesophageal and gastric cancer Gut, June 1, 2002; 50 (2007): v1 - v23. [Full Text] [PDF] |
||||
![]() |
H. J. V. Braga, M. A. Choti, V. S. Lee, E. K. Paulson, E. S. Siegelman, and D. A. Bluemke Liver Lesions: Manganese-enhanced MR and Dual-Phase Helical CT for Preoperative Detection and Characterization—Comparison with Receiver Operating Characteristic Analysis Radiology, May 1, 2002; 223(2): 525 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Varallyay, G. Nesbit, L. L. Muldoon, R. R. Nixon, J. Delashaw, J. I. Cohen, A. Petrillo, D. Rink, and E. A. Neuwelt Comparison of Two Superparamagnetic Viral-Sized Iron Oxide Particles Ferumoxides and Ferumoxtran-10 with a Gadolinium Chelate in Imaging Intracranial Tumors AJNR Am. J. Neuroradiol., April 1, 2002; 23(4): 510 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Raman, D. S. K. Lu, S. C. Chen, J. Sayre, F. Eilber, and J. Economou Hepatic MR Imaging Using Ferumoxides: Prospective Evaluation with Surgical and Intraoperative Sonographic Confirmation in 25 Cases Am. J. Roentgenol., October 1, 2001; 177(4): 807 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsuo, M. Kanematsu, K. Itoh, K. Ito, Y. Maetani, H. Kondo, N. Kako, N. Matsunaga, H. Hoshi, and J. Shiraishi Detection of Malignant Hepatic Tumors: Comparison of Gadolinium-and Ferumoxide-Enhanced MR Imaging Am. J. Roentgenol., September 1, 2001; 177(3): 637 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lim, D. Choi, S. K. Cho, S. H. Kim, W. J. Lee, H. K. Lim, C. K. Park, S. W. Paik, and Y. I. Kim Conspicuity of Hepatocellular Nodular Lesions in Cirrhotic Livers at Ferumoxides-enhanced MR Imaging: Importance of Kupffer Cell Number Radiology, September 1, 2001; 220(3): 669 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Mann, H. F. Marx, L. L. Lai, and L. D. Wagman Clinical and Cost Effectiveness of a New Hepatocellular MRI Contrast Agent, Mangafodipir Trisodium, in the Preoperative Assessment of Liver Resectability Ann. Surg. Oncol., August 1, 2001; 8(7): 573 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Dekker, E. J. van der Jagt, J. T. M. van Leeuwen, G. T. van der Werf, and M. G. M. Hunink Role of Abdominal Sonography in Excluding Abdominal Malignancy in the Initial Workup of Patients with Abdominal Complaints Am. J. Roentgenol., July 1, 2001; 177(1): 47 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Choi, S. H. Kim, J. H. Lim, W. J. Lee, H.-J. Jang, S. J. Lee, and H. K. Lim Preoperative Detection of Hepatocellular Carcinoma: Ferumoxides-Enhanced MR Imaging Versus Combined Helical CT During Arterial Portography and CT Hepatic Arteriography Am. J. Roentgenol., February 1, 2001; 176(2): 475 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Cuenod, I. Leconte, N. Siauve, A. Resten, C. Dromain, B. Poulet, F. Frouin, O. Clément, and G. Frija Early Changes in Liver Perfusion Caused by Occult Metastases in Rats: Detection with Quantitative CT Radiology, February 1, 2001; 218(2): 556 - 561. [Abstract] [Full Text] |
||||
![]() |
R. C. Semelka and T. K. G. Helmberger Contrast Agents for MR Imaging of the Liver Radiology, January 1, 2001; 218(1): 27 - 38. [Abstract] [Full Text] |
||||
![]() |
D. A. Bluemke, E. K. Paulson, M. A. Choti, S. DeSena, and P. A. Clavien Detection of Hepatic Lesions in Candidates for Surgery: Comparison of Ferumoxides-Enhanced MR Imaging and Dual-Phase Helical CT Am. J. Roentgenol., December 1, 2000; 175(6): 1653 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mori, H. Yoshioka, Y. Itai, Y. Okamoto, H. Mori, N. Takahashi, and Y. Saida Arterioportal Shunts in Cirrhotic Patients: Evaluation of the Difference Between Tumorous and Nontumorous Arterioportal Shunts on MR Imaging with Superparamagnetic Iron Oxide Am. J. Roentgenol., December 1, 2000; 175(6): 1659 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Reimer, N. Jähnke, M. Fiebich, W. Schima, F. Deckers, C. Marx, N. Holzknecht, and S. Saini Hepatic Lesion Detection and Characterization: Value of Nonenhanced MR Imaging, Superparamagnetic Iron Oxide-enhanced MR Imaging, and Spiral CT-ROC Analysis Radiology, October 1, 2000; 217(1): 152 - 158. [Abstract] [Full Text] |
||||
![]() |
C. J. Harvey, M. J. K. Blomley, R. J. Eckersley, D. O. Cosgrove, N. Patel, R. A. Heckemann, and J. Butler-Barnes Hepatic Malignancies: Improved Detection with Pulse-Inversion US in Late Phase of Enhancement with SH U 508A-Early Experience Radiology, September 1, 2000; 216(3): 903 - 908. [Abstract] [Full Text] |
||||
![]() |
H. Kondo, M. Kanematsu, H. Hoshi, T. Murakami, T. Kim, M. Hori, M. Matsuo, and H. Nakamura Preoperative Detection of Malignant Hepatic Tumors: Comparison of Combined Methods of MR Imaging with Combined Methods of CT Am. J. Roentgenol., April 1, 2000; 174(4): 947 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ward, F. Chen, J. A. Guthrie, D. Wilson, J. P. A. Lodge, J. I. Wyatt, and P. J. Robinson Hepatic Lesion Detection after Superparamagnetic Iron Oxide Enhancement: Comparison of Five T2-weighted Sequences at 1.0 T by Using Alternative-Free Response Receiver Operating Characteristic Analysis1 Radiology, January 1, 2000; 214(1): 159 - 166. [Abstract] [Full Text] |
||||
![]() |
T. Postert, B Lack, W Kuhn, M Jergas, J Andrich, B Braun, H Przuntek, R Sprengelmeyer, M Agelink, and T. Buttner Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography J. Neurol. Neurosurg. Psychiatry, October 1, 1999; 67(4): 457 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ward, K. S. Naik, J. A. Guthrie, D. Wilson, and P. J. Robinson Hepatic Lesion Detection: Comparison of MR Imaging after the Administration of Superparamagnetic Iron Oxide with Dual-Phase CT by Using Alternative–Free Response Receiver Operating Characteristic Analysis Radiology, February 1, 1999; 210(2): 459 - 466. [Abstract] [Full Text] |
||||
![]() |
F. Forsberg, C. W. Piccoli, J.-B. Liu, N. M. Rawool, D. A. Merton, D. G. Mitchell, and B. B. Goldberg Hepatic Tumor Detection: MR Imaging and Conventional US versus Pulse-Inversion Harmonic US of NC100100 during Its Reticuloendothelial System-Specific Phase Radiology, March 1, 2002; 222(3): 824 - 829. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |